X @Bloomberg
AstraZeneca's profit rose more than analysts anticipated last quarter, buoyed by sales of its blockbuster cancer and diabetes drugs https://t.co/Ffzec03P1L ...
AstraZeneca's profit rose more than analysts anticipated last quarter, buoyed by sales of its blockbuster cancer and diabetes drugs https://t.co/Ffzec03P1L ...